Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)
Clinical trial NCT04805827 · COMPLETED
Trial details
- NCT number
- NCT04805827
- Sponsor
- Pharma Guide CRO
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-03-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.